Melioidosis (Q56286799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Melioidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

ChEBI release 2020-05-28

N J White

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

volume

361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

issue

9370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1715-1722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

An Account of a Glanders-like Disease occurring in Rangoon

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis--a military medical problem?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Recrudescent Melioidosis: A Southeast Asian Legacy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis: the tip of the iceberg?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis and Pandora's box in the Lao People's Democratic Republic

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Septicaemic melioidosis: a review of 50 cases from Malaysia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis: an emerging infection in Taiwan?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis research in China

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

An improved screening technique for isolation of pseudomonas pseudomallei from clinical specimens

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Aminoglycoside and macrolide resistance in Burkholderia pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Oral fluoroquinolones for maintenance treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Survival of Burkholderia pseudomallei in the absence of nutrients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Current studies on the pathogenesis of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Purification and characterization of a protease from Pseudomonas pseudomallei.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

The histopathology of human melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Prognostic significance of quantitative bacteremia in septicemic melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Antilipopolysaccharide II: an antibody protective against fatal melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Tumor necrosis factor in septicemic melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

HLA-DR and -DQ associations with melioidosis.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Risk factors for melioidosis and bacteremic melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Chronic melioidosis in a patient with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Acute melioidosis outbreak in Western Australia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Mother-to-child transmission of Burkholderia pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Laboratory acquired melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Human-to-Human Transmission of Pseudomonas pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Pseudomonas pseudomallei liver abscesses: a clinical, laboratory, and ultrasonographic study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis in the Northern Territory of Australia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Corneal ulcer caused by Pseudomonas pseudomallei: report of three cases.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Acute suppurative parotitis caused by Pseudomonas pseudomallei in children

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Neurological melioidosis: seven cases from the Northern Territory of Australia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Visceral organ abscesses in melioidosis: sonographic findings

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Demonstration of different patterns of musculoskeletal, soft tissue and visceral involvement in melioidosis using 99m Tc stannous colloid white cell scanning

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Value of throat swab in diagnosis of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Selective broths for the isolation of Pseudomonas pseudomallei from clinical samples

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Speed of Detection of Burkholderia pseudomallei in Blood Cultures and its Correlation with the Clinical Outcome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

A comparison of lysis centrifugation, pour plate, and conventional blood culture methods in the diagnosis of septicaemic melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Latex agglutination test for identification of Pseudomonas pseudomallei

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Immunofluorescence microscopy for the rapid diagnosis of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Halving of mortality of severe melioidosis by ceftazidime

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Empirical cephalosporin treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Comparison of imipenem and ceftazidime as therapy for severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis: acute and chronic disease, relapse and re-activation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Amoxycillin-clavulanic acid treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Paediatric melioidosis in the Northern Territory of Australia: an expanding clinical spectrum

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Neurological melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Melioidosis as an emerging global problem

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

Interactions in vitro between agents used to treat melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(03)13374-0

7 January 2021

10.1016/S0140-6736(03)13374-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767750 AND SRC:MED&resulttype=core&format=json

4 November 2019

1 reference